Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.
Clinical trial NCT01966107 · COMPLETED
Trial details
- NCT number
- NCT01966107
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-16
- Primary completion
- 2017-09-21
- Enrollment
- 3635
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.